Hamilton Thorne Ltd.
HTL
Rank in Stocks
#16935
Hamilton Thorne Ltd. is a leading enterprise focused on the development,... Hamilton Thorne Ltd. is a leading enterprise focused on the development, manufacturing, and global distribution of specialized instrumentation, laboratory equipment, consumables, software, and a range of services. The company's offerings are primarily directed towards the fields of assisted reproductive technologies (ART), scientific research, and cell biology. Their product line includes sophisticated laser and imaging systems designed for biological studies, custom-built workstations, incubators, and essential equipment for IVF laboratories. They also produce critical medical devices for reproductive medicine, such as ovum pickup needles and catheters, and provide comprehensive in-vitro diagnostic (IVD) systems, from initial research and design to sales, installation, and ongoing servicing. Environmental control solutions like the Cell-Tek Microscope Chamber, which meticulously manages temperature, airflow, and humidity, are also part of their extensive catalog, alongside laminar flow workstations. Furthermore, Hamilton Thorne pioneers software innovations, including AI-powered CASA (Computer-Assisted Sperm Analysis) for image analysis. The company's service array covers thorough laboratory testing, notably endotoxin analysis and specialized sperm assays (like the Sperm Motility Index and Sperm Penetration), as well as the provision of fresh and cryopreserved mouse embryos, coupled with technician training and proficiency testing programs. Marketed under respected brand names such as Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech, their products and services reach a diverse global customer base—including fertility clinics, hospitals, pharmaceutical and biotechnology companies, academic institutions, and various commercial research entities—via a direct sales presence in countries like the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, complemented by an extensive distributor network covering around 100 nations. Hamilton Thorne Ltd. maintains its headquarters in Beverly, Massachusetts.
Share Price
$1.64
Last synced: 2024-12-02
Market Cap
$253.46M
Change (1 day)
2.87%
Change (1 year)
3.40%
Country
US
Trade Hamilton Thorne Ltd. (HTL)
Category
Healthcare
Revenue for Hamilton Thorne Ltd. (HTL)
Revenue in Sep 2024 TTM: $76.72M
According to Hamilton Thorne Ltd. latest financial reports the company's current revenue (TTM) is $76.72M. In 2022 the company made a revenue of $55.87M an increase over the revenue in the year 2021 that was $52.35M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Hamilton Thorne Ltd. from 2008 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $76.72M | 14.13% |
| 2023 | $67.23M | 20.32% |
| 2022 | $55.87M | 6.72% |
| 2021 | $52.35M | 31.61% |
| 2020 | $39.78M | 12.50% |
| 2019 | $35.36M | 21.03% |
| 2018 | $29.21M | 32.06% |
| 2017 | $22.12M | 110.38% |
| 2016 | $10.51M | 16.39% |
| 2015 | $9.03M | 3.75% |
| 2014 | $8.71M | 16.45% |
| 2013 | $7.48M | 18.20% |
| 2012 | $6.33M | -11.64% |
| 2011 | $7.16M | 15.46% |
| 2010 | $6.20M | 29.32% |
| 2009 | $4.79M | 13,987.95% |
| 2008 | $34.03K | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $11.03B | 14,282.21% |
US
|
|
| $34.74B | 45,175.54% |
FR
|
|
| - | - |
JP
|
|
| $20.84B | 27,061.50% |
US
|
|
| - | - |
CH
|
